hRAD54 Gene Polymorphism and Chronic Myelogenous Leukemia
Author Information
Author(s): César Paz-y-Miño, Andrés López-Cortés, María José Muñoz, Bernardo Castro, Alejandro Cabrera, María Eugenia Sánchez
Primary Institution: Instituto de Investigaciones Biomédicas, Facultad de Ciencias de la Salud, Universidad de las Américas, Quito, Ecuador
Hypothesis
Is there a relationship between the hRAD54 gene polymorphism (2290 C/T) and chronic myelogenous leukemia in an Ecuadorian population?
Conclusion
The study suggests a possible link between the 2290 C/T polymorphism of the hRAD54 gene and chronic myelogenous leukemia.
Supporting Evidence
- The 2290 C/T polymorphism has frequencies of 0.1 for both leukemia and control groups.
- In the CML subgroup, the frequency was 0.14, showing significant differences from the control group.
- No significant differences were found between the ALL subgroup and the control group.
Takeaway
Scientists looked at a gene that might be linked to a type of blood cancer called chronic myelogenous leukemia, and they found some interesting connections.
Methodology
The hRAD54 gene polymorphism was analyzed using PCR-SSCP method in 239 samples, including leukemia patients and a control group.
Limitations
The sample size is not large, which may limit the interpretation of the results.
Participant Demographics
239 Ecuadorian individuals, including 137 with leukemia (61 ALL, 1 CLL, 15 AML, 60 CML) and 102 healthy controls.
Statistical Information
P-Value
p < 0.05 for CML vs control, p > 0.05 for ALL vs control
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website